Quality Assurance (QA) Manager to Nanexa AB
Nanexa is now recruiting a Quality Assurance (QA) Manager. The position is full-time and based...
Read more
Nanexa’s PharmaShell® technology is transforming the face of long-acting ’super generic’ drugs with its proprietary suite of Atomic Layer Deposition (ALD) technologies.
PharmaShell formulations will allow indications including type 2 diabetes/obesity, cancers, cardiovascular and psychiatric disorders to be treated with monthly injections.
27 August, 2026
Strong commitment and a focus on the commercial side of the business.
READ MORE18 June, 2026
An intensive first half-year sets the stage for an interesting continuation
READ MORE27 August 2026
18–20 May 2026
29 April 2026
19 February 2026